Reading Time: 4 minutesWith all the talk of new gene discoveries in recent years, the Sunday morning scientific session returned to the original discovery in 1993 that mutations
Category: Treatments
Reading Time: 4 minutesThe 25th International Symposium on ALS/MND began today in Brussels, Belgium. More than 900 delegates joined the opening session to hear Dr Alfred Sandrock from
Reading Time: 2 minutesEver since the G8 summit on Dementia less than a year ago there has been a huge upsurge in international research activity in the field.
Reading Time: 4 minutesOn 22 September 2014 Neuralstem announced the results from their long-term follow up of three participants who were involved in their initial phase I safety
Reading Time: 5 minutesA question was submitted to the Association’s AGM last weekend, which could only be answered in brief at the time, due to the number of
Causes and disease mechanisms Markers of Disease Progression MND Research Models of MND Research we fund Treatments
Very ‘ice’ research
Reading Time: 3 minutesThe ALS #icebucketchallenge, which started in America, has now well and truly hit the UK! The social media craze has seen thousands of people getting
Reading Time: 4 minutesA number of articles were published in various news sources on 11 July 2014, highlighting how scientists in Sheffield are working towards testing a promising
Reading Time: 5 minutesDr Tennore Ramesh is based at the Sheffield Institute for Translational Neuroscience (SITraN) based at the University of Sheffield. His Association funded research is investigating
Reading Time: 2 minutesDr Richard Bedlack is based at the Duke ALS Clinic in America. Back in 2009 he founded ALSUntangled and to start off MND Awareness week
Reading Time: 2 minutesIn the Sheffield Institute for Translational Neuroscience (SITraN), the gene therapy group led by Prof Mimoun Azzouz is approaching the final stages of preclinical development